What is the patent situation for berotralstat?
Berotralstat, a treatment for hereditary angioedema (HAE), is protected by multiple patents. These patents cover the composition of matter, methods of use, and manufacturing processes related to the drug. The patent landscape for berotralstat is complex, with various patents filed and granted at different times, each with its own expiration date.
When do berotralstat's key patents expire?
The primary composition of matter patent for berotralstat is set to expire in 2030 [1]. However, other patents related to its formulation or method of use may have different expiration timelines. Navigating these different patent terms is crucial for understanding when generic or biosimilar competition might emerge.
Are there any challenges to berotralstat's patents?
Patent challenges are a common strategy in the pharmaceutical industry to potentially accelerate the entry of generic competitors. While specific details about ongoing or past legal challenges to berotralstat's patents are not publicly detailed in the provided information, it is a general practice that drug patents, especially for high-value medications, are subject to scrutiny and potential litigation from generic manufacturers [2].
How does berotralstat work?
Berotralstat functions as a plasma kallikrein inhibitor [1]. By inhibiting plasma kallikrein, it prevents the overproduction of bradykinin, a key mediator in the swelling attacks characteristic of HAE. This mechanism of action addresses the underlying cause of HAE symptoms.
What are the approved uses for berotralstat?
Berotralstat is approved for the prophylactic (preventative) treatment of attacks in adult patients with hereditary angioedema [1]. This means it is designed to reduce the frequency and severity of HAE attacks rather than treat an acute attack once it has started.
Who manufactures berotralstat?
BioCryst Pharmaceuticals is the developer and manufacturer of berotralstat [1]. The company has been instrumental in bringing this therapy to HAE patients.
Where can I find more detailed patent information for berotralstat?
For comprehensive and up-to-date information on drug patents, including those for berotralstat, resources like DrugPatentWatch.com can provide detailed patent filings, expiration dates, and legal status [2].
---
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/